Skip to content
Trial Agents

Clinical Logistics

Clinical Logistics is recorded as a service provider in 11 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

11distinct trials
8recorded service labels
1trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 11 of 11 trials · Latest update first

A Phase 3, Double-blind, Randomized Study of Zolbetuximab in Combination with Pembrolizumab and Chemotherapy (CAPOX or mFOLFOX6) in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in Participants Whose Tumors are HER2-negative, Claudin (CLDN) 18.2-positive and Programmed Death-ligand 1 (PD-L1)-positive

Sponsor Astellas Pharma Global Development Inc.

Start (EU)
Latest update
Estimated end

C3441052 - TALAPRO-3: A Phase 3, Randomized, Double-Blind Study of Talazoparib with Enzalutamide Versus Placebo with Enzalutamide in Men with DDR Gene Mutated Metastatic Castration-Sensitive Prostate Cancer

Sponsor Pfizer Inc.

Start (EU)
Latest update
Estimated end

A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants with BCG-naïve High-Risk Non-Muscle Invasive Bladder Cancer (HRNMIBC)

Sponsor Janssen - Cilag International

Start (EU)
Latest update
Estimated end

A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared with Investigator’s Choice in HLA-A*0201 Positive Patients with Previously Untreated Advanced Uveal Melanoma

Sponsor Immunocore Limited

Start (EU)
Latest update
Estimated end
Operational learnings available2 trial-level findings · Read insights
  • The study randomized 378 patients at 58 sites in 14 countries.
  • Tebentafusp required at least 16 hours of inpatient monitoring after dosing on Cycle 1 Days 1, 8, and 15 because of anticipated cytokine release syndrome.

These findings describe the trial, not the service provider’s performance or responsibility.

A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Sponsor Relay Therapeutics Inc.

Start (EU)
Latest update
Estimated end

LOGGIC/FIREFLY-2: A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy

Sponsor Day One Biopharmaceuticals Inc.

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Clinical Logistics?

The 2026-10-09 snapshot links Clinical Logistics to 11 distinct CTIS trials. Recorded services include Laboratory services, Medical expertise, 1. Preparation of lab kits &labels 2. Preparation of lab manuals & other lab documents 3. Inventory, Kit supplies and sample shipment, among 8 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Clinical Logistics?

The most frequently recorded therapeutic areas are Solid Tumor Oncology, Urology, Gastroenterology, Haematological Malignancies. Recorded phases include Phase 3, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Clinical Logistics conducted?

The linked trials record locations in 22 countries, including Spain, France, Germany, Italy, Czechia. These are trial locations, not confirmed office locations or countries where Clinical Logistics delivered services.

What can this page tell me about Clinical Logistics's trial experience?

Browse 11 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Clinical Logistics. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Clinical Logistics Inc.

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.

By entering your email, you agree to receive emails from Trial Agents. You can unsubscribe anytime.